A detailed history of Missouri Trust & Investment CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Missouri Trust & Investment CO holds 200 shares of AZN stock, worth $13,272. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$13,272
Previous $15,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$61.89 - $69.28 $1,361 - $1,524
-22 Reduced 9.91%
200 $13,000
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $1,538 - $1,667
22 Added 11.0%
222 $15,000
Q4 2021

Feb 02, 2022

BUY
$54.02 - $63.83 $10,804 - $12,766
200 New
200 $12,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Missouri Trust & Investment CO Portfolio

Follow Missouri Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.